Kilpatrick, I C <br/><br/>
Monoamine oxidase inhibition is unlikely to be relevant to the risks associated with phentermine and fenfluramine: a comparison with their abilities to evoke monoamine release.  [electronic resource] 

 -  International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity  Oct 2001 
 - 1454-8 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>Standard No.: </label>10.1038/sj.ijo.0801732  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Brain--drug effects<br/>Cardiovascular Diseases--chemically induced<br/>Fenfluramine--pharmacology<br/>Male<br/>Monoamine Oxidase--metabolism<br/>Monoamine Oxidase Inhibitors--pharmacology<br/>Phentermine--pharmacology<br/>Rats<br/>Rats, Sprague-Dawley<br/>Selective Serotonin Reuptake Inhibitors